Between 2019 and 2023, the number of GLP-1 prescriptions increased by more than 400%, while spending increased by more than 500%
Semaglutide is approved in different forms for specific medical uses, depending on the brand name and labeling: Ozempic (semaglutide injection) Type 2 diabetes (T2D): to improve blood sugar control in adults Cardiovascular (CV) risk reduction: to reduce the risk of major cardiovascular events (such as heart attack or stroke) in certain adults with type 2 diabetes and known heart disease Wegovy (semaglutide injection) Chronic weight management: for eligible patients based on BMI criteria and clinical guidelines Adolescents ages 12+: approved for chronic weight management in adolescents who meet the label criteria Quick warning: Dont assume that what you see on social media reflects an FDA-approved use
Pharmacogenetics in clinical pharmacology and toxicology
Metformin remains the first-line therapy for newly diagnosed pediatric patients
A 2023 analysis of GLP-1 therapy found that participants who combined medication with structured exercise programs retained 80-90% of their lean muscle mass while losing substantial fat
In the present study, we carried forward these four ACs and tested whether the relationships with depression predicted from genomic data (negative with C2 and C3, and positive with C8 and C10) were expressed in actual phenotypes measured in a large cohort (N ~ 2500) with extensive clinical phenotyping
